Physician profile
Amanda Yancy
NPI 1821003724
$14,785.04
in general payments reported to CMS, 2019-2025
24 companies · $8,318 in 2025
The $8,318 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,052 · 2020: $470 · 2021: $471 · 2022: $820 · 2023: $415 · 2024: $2,240 · 2025: $8,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $1,937 · Travel and Lodging: $1,013 · Gift: $23.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $1,936.63 |
| Travel and Lodging | $1,012.85 |
| Gift | $23.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,889.71 | 2019-2025 | |
| Abbvie INC. | $681.57 | 2019-2022 | |
| Myovant Sciences INC. | $678.78 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $550.55 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $133.66 | 2019-2020 | |
| Smith+Nephew, INC. | $111.13 | 2019-2021 | |
| Hologic Sales and Service, LLC | $102.76 | 2022-2025 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $85.83 | 2019-2023 | Slynd |
| Pfizer INC. | $81.24 | 2022-2024 | |
| Scynexis, INC. | $54.69 | 2022 | |
| Baxter Healthcare | $49.58 | 2024-2025 | Seprafilm, Perclot |
| Coopersurgical, INC. | $47.51 | 2019-2025 | Paragard T 380a |
| Lupin INC. | $41.63 | 2019 | |
| Organon LLC | $40.47 | 2022-2024 | |
| Astellas Pharma US INC | $37.67 | 2024 | Veozah |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $36.28 | 2019-2020 | |
| Convatec INC. | $35.47 | 2023 | |
| Medicem INC. | $28.12 | 2020 | |
| Abbott Laboratories | $22.52 | 2021 | |
| Sage Therapeutics, LLC | $20.94 | 2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $17.31 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.96 | 2019 | |
| Agile Therapeutics, INC. | $11.66 | 2021 | |
| Covidien LP | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Yancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.